Suspension of trading
Centessa Pharmaceuticals plc Stock
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-06-23 EDT
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.39B 5.08B 4.63B 8.66B 596B 8.69B 60.18B 23.26B 304B 23.53B 23.02B 962B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.24B 4.93B 4.5B 8.41B 580B 8.45B 58.49B 22.6B 295B 22.87B 22.37B 935B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +1.86% | ||
| 6 months | +55.23% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 17.05 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 2024-09-30 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 2023-02-28 |
David Chao
ADM | Chief Administrative Officer | 58 | 2021-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2026-06-23 | |
Kristina Wright
BRD | Director/Board Member | - | 2026-06-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/24/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 5/1/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 3/26/26 | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +94.24% | +526.93% | 6.27B | |
| +0.78% | -6.98% | -2.73% | +11.12% | 46.38B | |
| +0.17% | -0.74% | +407.28% | +546.58% | 44.51B | |
| -0.86% | -2.60% | +35.51% | +20.35% | 42.3B | |
| -0.14% | -2.98% | -0.04% | +82.21% | 39.91B | |
| 0.00% | -1.72% | +13.42% | +42.33% | 32.79B | |
| -3.44% | -2.43% | - | - | 17.13B | |
| -0.78% | -1.13% | +20.74% | +116.26% | 16.36B | |
| +0.48% | -3.76% | +12.33% | +30.49% | 14.31B | |
| -0.86% | -4.60% | +76.86% | +39.36% | 13.29B | |
| Average | -0.47% | -2.41% | +73.07% | +157.29% | 27.32B | |
| Weighted average by Cap. | -0.29% | -2.93% | +86.18% | +142.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 12.91 12.15 11.07 20.72 1.43K 20.8 144.04 55.67 727.16 56.32 55.1 2.3K |
| Net income | -236M -203M -191M -174M -326M -22.43B -327M -2.26B -875M -11.43B -885M -866M -36.21B | -198M -170M -160M -146M -273M -18.8B -274M -1.9B -733M -9.58B -742M -726M -30.34B |
| Net Debt | -364M -314M -295M -269M -503M -34.67B -505M -3.5B -1.35B -17.66B -1.37B -1.34B -55.96B | -176M -152M -143M -130M -243M -16.77B -244M -1.69B -654M -8.54B -662M -647M -27.06B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
